COVID-19

June 25, 2020

Coronavirus and the Economic Value of Human Life

The Covid-19 crisis has provided many grim examples of some familiar problems in health economics and cost-benefit analysis, and of the ‘tragic choices’ that sometimes need to be made.
June 19, 2020

The Fake American Stimulation: an Economic Analysis of Coronavirus Aid, Relief, and Economic Security (Cares) Act

We almost pity American federal and state elected officials for having to deal with the situation caused by COVID-19. Overnight, social media users have become self-proclaimed epidemiologists, but it remains difficult to judge whether the measures taken by states and the federal government are too little too late or the right response to a health crisis. In some ways, it is tempting to favour the federal responses to the economic crisis as the circumstances are unlike those of previous crises.
June 18, 2020

Inflation: the Next Threat?

The policy reaction to the Covid-19 pandemic will increase budget deficits massively in all the world’s leading countries. The deficits will to a significant extent be monetised, with heavy state borrowing from both national central banks and commercial banks.
June 17, 2020

Vaccine: We Must Change Our Absurd Rules Instead of Castigating Sanofi

Excessively high taxes on production, exceedingly slow authorizations for market launch, and an overbearing bureaucracy. France is ensuring that innovation, especially regarding pharmaceuticals, happens outside of its borders. Opinion piece by Cécile Philippe, president of the Economic Institute Molinari, published in Les Echos.